Global Active Pharmaceutical Ingredients Market to reach USD 294.8 billion by 2027.

Global Active Pharmaceutical Ingredients Market Size study, by Type of Synthesis (Biotech, Synthetic, Vaccines, Monoclonal Antibodies and Recombinant Proteins), by Type of Manufacturer (Captive API and Merchant API), by Type (Generic and Innovative APIs), by Application (Cardiovascular Diseases, Oncology, Orthopedics, Nephrology and Others), and Regional Forecasts 2021-2027
Product Code:  HALDAT_71618664
 Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1.	Active Pharmaceutical Ingredients Market, by Type of Synthesis, 2019-2027 (USD Billion)
1.2.2.	Active Pharmaceutical Ingredients Market, by Type of Manufacturer, 2019-2027 (USD Billion)
1.2.3.	Active Pharmaceutical Ingredients Market, by Type, 2019-2027 (USD Billion)
1.2.4.	Active Pharmaceutical Ingredients Market, by Application, 2019-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Active Pharmaceutical Ingredients Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Active Pharmaceutical Ingredients Market Dynamics	
3.1.	Active Pharmaceutical Ingredients Market Impact Analysis (2019-2027)
3.1.1.	Market Drivers
3.1.1.1.	Exponential growth of pharmaceutical industry
3.1.1.2.	Governmental proposed policies and schemes
3.1.2.	Market Challenges
3.1.2.1.	High cost of production of APIs
3.1.3.	Market Opportunities
3.1.3.1.	Increase in lifestyle diseases such as diabetes and cardiovascular
Chapter 4.	Global Active Pharmaceutical Ingredients Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Active Pharmaceutical Ingredients Market, by Type of Synthesis
5.1.	Market Snapshot 
5.2.	Global Active Pharmaceutical Ingredients Market by Type of Synthesis, Performance - Potential Analysis
5.3.	Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type of Synthesis 2018-2027 (USD Billion)
5.4.	Active Pharmaceutical Ingredients Market, Sub Segment Analysis
5.4.1.	Biotech API
5.4.2.	Monoclonal Antibodies
5.4.3.	Recombinant Proteins
5.4.4.	Vaccines
5.4.5.	Synthetic API
Chapter 6.	Global Active Pharmaceutical Ingredients Market, by Type of Manufacturer
6.1.	Market Snapshot 
6.2.	Global Active Pharmaceutical Ingredients Market by Type of Manufacturer, Performance - Potential Analysis
6.3.	Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type of Manufacturer 2018-2027 (USD Billion)
6.4.	Active Pharmaceutical Ingredients Market, Sub Segment Analysis
6.4.1.	Captive API
6.4.2.	Merchant API
Chapter 7.	Global Active Pharmaceutical Ingredients Market, by Type
7.1.	Market Snapshot 
7.2.	Global Active Pharmaceutical Ingredients Market by Type, Performance - Potential Analysis
7.3.	Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
7.4.	Active Pharmaceutical Ingredients Market, Sub Segment Analysis
7.4.1.	Generic APIS
7.4.2.	Innovative APIs
Chapter 8.	Global Active Pharmaceutical Ingredients Market, by Application
8.1.	Market Snapshot 
8.2.	Global Active Pharmaceutical Ingredients Market by Application, Performance - Potential Analysis
8.3.	Global Active Pharmaceutical Ingredients Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
8.4.	Active Pharmaceutical Ingredients Market, Sub Segment Analysis
8.4.1.	Cardiovascular Diseases
8.4.2.	Oncology
8.4.3.	CNS and Neurology
8.4.4.	Orthopedics
8.4.5.	Endocrinology
8.4.6.	Pulmonology
8.4.7.	Gastroenterology
8.4.8.	Nephrology
8.4.9.	Ophthalmology
8.4.10.	Others
Chapter 9.	Global Active Pharmaceutical Ingredients Market, Regional Analysis
9.1.	Active Pharmaceutical Ingredients Market, Regional Market Snapshot 
9.2.	North America Active Pharmaceutical Ingredients Market 
9.2.1.	U.S. Active Pharmaceutical Ingredients Market
9.2.1.1.	Type of Synthesis breakdown estimates & forecasts, 2018-2027 
9.2.1.2.	Type of Manufacturer breakdown estimates & forecasts, 2018-2027
9.2.1.3.	Type breakdown estimates & forecasts, 2018-2027
9.2.1.4.	Application breakdown estimates & forecasts, 2018-2027
9.2.2.	Canada Active Pharmaceutical Ingredients Market
9.3.	Europe Active Pharmaceutical Ingredients Market Snapshot
9.3.1.	U.K. Active Pharmaceutical Ingredients Market 
9.3.2.	Germany Active Pharmaceutical Ingredients Market
9.3.3.	France Active Pharmaceutical Ingredients Market
9.3.4.	Spain Active Pharmaceutical Ingredients Market
9.3.5.	Italy Active Pharmaceutical Ingredients Market
9.3.6.	Rest of Europe Active Pharmaceutical Ingredients Market
9.4.	Asia-Pacific Active Pharmaceutical Ingredients Market Snapshot
9.4.1.	China Active Pharmaceutical Ingredients Market 
9.4.2.	India Active Pharmaceutical Ingredients Market 
9.4.3.	Japan Active Pharmaceutical Ingredients Market
9.4.4.	Australia Active Pharmaceutical Ingredients Market
9.4.5.	South Korea Active Pharmaceutical Ingredients Market
9.4.6.	Rest of Asia Pacific Active Pharmaceutical Ingredients Market
9.5.	Latin America Active Pharmaceutical Ingredients Market Snapshot
9.5.1.	Brazil Active Pharmaceutical Ingredients Market
9.5.2.	Mexico Active Pharmaceutical Ingredients Market
9.6.	Rest of The World Active Pharmaceutical Ingredients Market
Chapter 10.	Competitive Intelligence
10.1.	Top Market Strategies
10.2.	Company Profiles
10.2.1.	 AbbVie, Inc.
10.2.1.1.	Key Information
10.2.1.2.	Overview
10.2.1.3.	Financial (Subject to Data Availability)
10.2.1.4.	Product Summary
10.2.1.5.	Recent Developments
10.2.2.	Boehringer Ingelheim International GmbH
10.2.3.	Bristol-Myers Squibb Company
10.2.4.	Cipla, Inc.
10.2.5.	Merck & Co., Inc.
10.2.6.	Albemarle Corporation
10.2.7.	Aurobindo Pharma
10.2.8.	Viatris Inc. (Mylan N.V.)
10.2.9.	Teva Pharmaceutical Industries Ltd.
10.2.10.	Sun Pharmaceutical Industries Ltd.
Chapter 11.	Research Process
11.1.	Research Process
11.1.1.	Data Mining
11.1.2.	Analysis
11.1.3.	Market Estimation
11.1.4.	Validation
11.1.5.	Publishing
11.2.	Research Attributes
11.3.	Research Assumption

Global Active Pharmaceutical Ingredients Market is valued approximately USD 184.8 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.90% over the forecast period 2021-2027. Active pharmaceutical ingredient is a substance or mixture of substances used in the manufacturing of a medicinal drug and becomes an active ingredient of the drug product, when used in the production of a drug. APIs are intended to furnish pharmacological activity or any other direct effect in the analysis, treatment, mitigation, diagnosis or prevention of a disease. The APIs are the building blocks of pharmaceutical industry. The exponential growth of the industry after the COVID-19 pandemic has increased the demand of APIs. Pharmaceutical supply chain was heavily disrupted during lockdowns in pandemic which resulted in shortage of APIs worldwide. The various governments, including Indian and other Asian countries, are now trying to ramp up the growth of APIs domestically to reduce the dependency on China. These efforts are also driving the growth of active pharmaceutical ingredients market. In 2020, Government of India announced Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of APIS, in which financial incentive will be given to eligible manufacturers of identified 41 eligible products which covers 53 APIs for 6 years. Another scheme from government allots INR 3000 Crores for providing financial assistance for construction of Common Infrastructure Facilities in 3 Bulk Drug Parks.

The high cost of setting up API production units and stringent safety regulations and governmental norms may act as a restraint for its growth. However, increasing chronic diseases due to lifestyle changes such as cardiovascular, respiratory and others act as an opportunity for growth of Active Pharmaceutical Ingredients Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Active Pharmaceutical Ingredients Market. Due to the presence of leading pharmaceutical formulation manufacturers as well as rise of lifestyle diseases, North America is a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the growing pharmaceuticals industries in emerging economies of China and India. Government backed schemes and policies will also boost growth of API market in this region.

Major market player included in this report are:
AbbVie, Inc.
Boehringer Ingelheim International GmbH
Bristol-Myers Squibb Company
Cipla, Inc.
Merck & Co., Inc.
Albemarle Corporation
Aurobindo Pharma
Viatris Inc. (Mylan N.V.)
Teva Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type of Synthesis:
Biotech API
Monoclonal Antibodies
Recombinant Proteins
Vaccines
Synthetic API

By Type of Manufacturer:
Captive API
Merchant API

By Type:
Generic APIS
Innovative APIs

By Application:
Cardiovascular Diseases
Oncology
CNS and Neurology
Orthopedics
Endocrinology
Pulmonology
Gastroenterology
Nephrology
Ophthalmology
Others

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Active Pharmaceutical Ingredients Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…